Skip to main content
Hangzhou Mdk Opto Electronics Co.,Ltd logo

Hangzhou Mdk Opto Electronics Co.,Ltd — Investor Relations & Filings

Ticker · 688079 ISIN · CNE1000053X1 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 576 across all filing types
Latest filing 2025-10-30 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 688079

About Hangzhou Mdk Opto Electronics Co.,Ltd

http://www.chinamdk.com/

Hangzhou Mdk Opto Electronics Co.,Ltd. specializes in the design, development, and mass production of high-precision optical components and thin-film coating solutions. Its primary product offerings include infrared cut-off filters, narrow bandpass filters, optical low-pass filters, and specialized micro-optical elements. These products are integral to the functionality of imaging modules in smartphones, automotive driver-assistance systems (ADAS), biometric identification devices, and smart home hardware. The company leverages advanced vacuum deposition and precision glass processing technologies to achieve high spectral performance and reliability. MDK provides customized optical solutions tailored to the requirements of global consumer electronics and automotive technology sectors, focusing on miniaturization and enhanced optical clarity.

Recent filings

Filing Released Lang Actions
国浩律师（上海）事务所关于美迪凯2024年股权激励计划回购注销、首次授予部分第一个解除限售期和行权期解除限售及解除行权条件成就的法律意见书
Regulatory Filings Classification · 80% confidence The document is a legal opinion letter issued by a law firm regarding the company’s 2024 stock option and restricted stock incentive plan, covering approvals, repurchase/cancellation actions, and satisfaction of exercise/unlock conditions. It is neither an annual/interim report nor a shareholder meeting presentation, nor a proxy, M&A, or earnings release. It also does not fit a specific transaction announcement category despite describing share repurchases—rather it is a specialist legal opinion attached to the company’s regulatory submissions. No dedicated category exists for legal opinions, so it falls under the miscellaneous Regulatory Filings (RNS) fallback.
2025-10-30 Chinese
杭州美迪凯光电科技股份有限公司关于2024年股票期权与限制性股票激励计划首次授予第一类限制性股票第一个解除限售期解除限售条件成就的公告
Capital/Financing Update Classification · 95% confidence The document is a detailed announcement from Hangzhou Medike Optoelectronics Technology Co., Ltd. regarding the achievement of conditions for the first unlocking period of restricted stocks under the 2024 stock option and restricted stock incentive plan. It includes specifics about the number of shares, the performance targets, the approval process, and legal opinions. The document is not a full annual or interim report, nor is it a financial statement or earnings release. It is a formal announcement about the unlocking of restricted shares as part of a stock incentive plan, which is a capital/financing update related to equity incentives. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (8564 characters) and content confirm it is a substantive announcement, not just a brief notice or a report publication announcement.
2025-10-30 Chinese
杭州美迪凯光电科技股份有限公司关于2024年股票期权与限制性股票激励计划首次授予股票期权第一个行权期采用自主行权的提示性公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the exercise period and conditions of a stock option and restricted stock incentive plan. It details the number of options, exercise price, eligible participants, and exercise arrangements. It does not contain financial statements or comprehensive financial data but rather focuses on the stock option plan and its execution. This type of document is typically classified as a Capital/Financing Update (CAP) because it relates to equity incentives and capital structure changes through stock options. The document length is short (1981 characters), and it is not a report publication announcement or a certification. Therefore, the best fitting category is CAP.
2025-10-30 Chinese
杭州美迪凯光电科技股份有限公司第三届董事会第六次会议决议公告
Board/Management Information Classification · 95% confidence The document is a board meeting resolution announcement from Hangzhou Medike Optoelectronics Technology Co., Ltd. It details the decisions made at the third board's sixth meeting, including approval of the 2025 Q3 report, stock option repurchases, and stock option exercise conditions. The document references other announcements and reports published on the Shanghai Stock Exchange website but does not itself contain the full quarterly report or detailed financial statements. The document is relatively short (2266 characters) and serves as an official announcement of board resolutions rather than the full report or financial data. Therefore, it fits best under Board/Management Information (MANG) as it announces board meeting decisions and management resolutions.
2025-10-30 Chinese
杭州美迪凯光电科技股份有限公司2025年第三季度报告
Interim / Quarterly Report Classification · 100% confidence The document is titled as the "2025 Third Quarter Report" of Hangzhou Medike Optoelectronics Technology Co., Ltd. It contains detailed financial data including balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the third quarter of 2025. The report is unaudited and covers a period shorter than a full fiscal year (specifically a quarter). The presence of comprehensive financial statements and analysis for a quarterly period clearly identifies this as an Interim / Quarterly Report. The document length is over 13,000 characters, indicating it is the full report, not just an announcement or summary. Therefore, the appropriate classification is Interim / Quarterly Report (IR). 9M 2025
2025-10-30 Chinese
杭州美迪凯光电科技股份有限公司关于公司2024年股票期权与限制性股票激励计划股票期权预留授予结果的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the company's 2024 stock option and restricted stock incentive plan, specifically about the reserved grant results of stock options. It details the approval process, the number of options granted, the exercise price, the list of incentive recipients, and the impact on financials. The document is relatively short (4300 characters) and is structured as a formal announcement of the stock option grant results rather than a full report or detailed financial statement. It does not contain comprehensive financial data or management discussion but focuses on the stock option grant event and related disclosures. This fits the category of a Capital/Financing Update (CAP), as it relates to company financing activities through stock option grants and equity incentives.
2025-09-26 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.